Ann Kolanowski1, Marie Boltz2, Elizabeth Galik3, Laura N Gitlin4, Helen C Kales5, Barbara Resnick3, Kimberly S Van Haitsma6, Amy Knehans7, Jane E Sutterlin8, Justine S Sefcik9, Wen Liu10, Darina V Petrovsky9, Lauren Massimo2, Andrea Gilmore-Bykovskyi11, Margaret MacAndrew12, Glenna Brewster13, Vycki Nalls14, Ying-Ling Jao2, Naomi Duffort15, Danny Scerpella16. 1. College of Nursing, Penn State, University Park, PA. Electronic address: amk20@psu.edu. 2. College of Nursing, Penn State, University Park, PA. 3. School of Nursing, University of Maryland, Baltimore, MD. 4. Department of Community-Public Health, Center for Innovative Care in Aging, Johns Hopkins School of Nursing, Baltimore, MD; Department of Psychiatry, Johns Hopkins School of Medicine, Baltimore, MD. 5. The Program for Positive Aging, University of Michigan, Ann Arbor, MI; VA Center for Clinical Management Research, Ann Arbor, MI. 6. Program for Person Centered Living Systems of Care, College of Nursing, The Pennsylvania State University, University Park, PA; Polisher Research Institute, Madlyn & Leonard Abramson Center for Jewish Life, North Wales, PA. 7. Penn State College of Medicine, Harrell Health Sciences Library, Research & Learning Commons, Hershey, PA. 8. Penn State, University Park, PA. 9. School of Nursing, University of Pennsylvania, Philadelphia, PA. 10. College of Nursing, The University of Iowa, Iowa City, IA. 11. School of Nursing, University of Wisconsin-Madison, Madison, WI. 12. Queensland University of Technology, Kelvin Grove, Queensland, Australia. 13. Center for Sleep and Circadian Neurobiology, Perelman School of Medicine, School of Nursing, University of Pennsylvania, Philadelphia, PA. 14. Optum Health, Rockville, MD. 15. Johns Hopkins School of Nursing, Baltimore, MD. 16. Center for Innovative Care in Aging, Johns Hopkins School of Nursing, Johns Hopkins University, Baltimore, MD.
Abstract
BACKGROUND: Behavioral and psychological symptoms of dementia (BPSD) are prevalent in people with neurodegenerative diseases. PURPOSE: In this scoping review the Kales, Gitlin and Lykestos framework is used to answer the question: What high quality evidence exists for the patient, caregiver and environmental determinants of five specific BPSD: aggression, agitation, apathy, depression and psychosis? METHOD: An a priori review protocol was developed; 692 of 6013 articles retrieved in the search were deemed eligible for review. Gough's Weight of Evidence Framework and the Cochrane Collaboration's tool for assessing risk of bias were used. The findings from 56 high quality/low bias articles are summarized. DISCUSSION: Each symptom had its own set of determinants, but many were common across several symptoms: neurodegeneration, type of dementia, severity of cognitive impairments, and declining functional abilities, and to a lesser extent, caregiver burden and communication. CONCLUSION: Research and policy implications are relevant to the National Plan to Address Alzheimer's Disease.
BACKGROUND: Behavioral and psychological symptoms of dementia (BPSD) are prevalent in people with neurodegenerative diseases. PURPOSE: In this scoping review the Kales, Gitlin and Lykestos framework is used to answer the question: What high quality evidence exists for the patient, caregiver and environmental determinants of five specific BPSD: aggression, agitation, apathy, depression and psychosis? METHOD: An a priori review protocol was developed; 692 of 6013 articles retrieved in the search were deemed eligible for review. Gough's Weight of Evidence Framework and the Cochrane Collaboration's tool for assessing risk of bias were used. The findings from 56 high quality/low bias articles are summarized. DISCUSSION: Each symptom had its own set of determinants, but many were common across several symptoms: neurodegeneration, type of dementia, severity of cognitive impairments, and declining functional abilities, and to a lesser extent, caregiver burden and communication. CONCLUSION: Research and policy implications are relevant to the National Plan to Address Alzheimer's Disease.
Authors: Christine R Kovach; Yavuz Taneli; Paul Dohearty; Andrea Matovina Schlidt; Susan Cashin; Amy L Silva-Smith Journal: Gerontologist Date: 2004-12
Authors: N Scarmeas; J Brandt; M Albert; D P Devanand; K Marder; K Bell; A Ciappa; B Tycko; Y Stern Journal: Neurology Date: 2002-04-23 Impact factor: 9.910
Authors: Clive G Ballard; Alan Thomas; Jane Fossey; Lesley Lee; Robin Jacoby; Marisa M Lana; Carol Bannister; Rupert McShane; Alan Swann; Ed Juszczak; John T O'Brien Journal: J Clin Psychiatry Date: 2004-01 Impact factor: 4.384
Authors: Iracema Leroi; Argyro Voulgari; John C S Breitner; Constantine G Lyketsos Journal: Am J Geriatr Psychiatry Date: 2003 Jan-Feb Impact factor: 4.105
Authors: Ann Kolanowski; Richard H Fortinsky; Margaret Calkins; Davangere P Devanand; Elizabeth Gould; Tamar Heller; Nancy A Hodgson; Helen C Kales; Jeffrey Kaye; Constantine Lyketsos; Barbara Resnick; Melanie Schicker; Sheryl Zimmerman Journal: J Am Med Dir Assoc Date: 2018-08-23 Impact factor: 4.669
Authors: Justine S Sefcik; Caroline Madrigal; Allison R Heid; Sheila L Molony; Kimberly Van Haitsma; Irene Best; Barbara Resnick; Elizabeth Galik; Marie Boltz; Ann Kolanowski Journal: J Gerontol Nurs Date: 2020-11-01 Impact factor: 1.254
Authors: Mark E Kunik; Melinda A Stanley; Srijana Shrestha; David Ramsey; Sheila Richey; Lynn Snow; Jessica Freshour; Tracy Evans; Michael Newmark; Susan Williams; Nancy Wilson; Amber B Amspoker Journal: Am J Geriatr Psychiatry Date: 2020-02-03 Impact factor: 4.105
Authors: Barbara Resnick; Elizabeth Galik; Ann Kolanowski; Kimberly Van Haitsma; Jeanette Ellis; Liza Behrens; Nina M Flanagan; Caroline McDermott Journal: J Am Med Dir Assoc Date: 2017-11-28 Impact factor: 4.669